Quick Answer
GILEAD SCIENCES, INC. reported Long-Term Debt of $22.13 billion for fiscal year 2025.
GILEAD SCIENCES, INC. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $22.13B | -11.1% |
| 2024 | $24.90B | +7.4% |
| 2023 | $23.19B | +1.0% |
| 2022 | $22.96B | -8.8% |
| 2021 | $25.18B | -12.1% |
| 2020 | $28.64B | +29.7% |
| 2019 | $22.09B | -10.1% |
| 2018 | $24.57B | -20.2% |
| 2017 | $30.80B | +16.9% |
| 2016 | $26.35B | +25.0% |
| 2015 | $21.07B | +76.8% |
| 2014 | $11.92B | +202.6% |
| 2013 | $3.94B | -44.2% |
| 2012 | $7.05B | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $22.14B | +3.3% | -0.0% |
| June 30, 2025 | $22.14B | +2.8% | -0.0% |
| March 31, 2025 | $22.15B | +2.9% | -11.0% |
| December 31, 2024 | $24.90B | +7.4% | +16.1% |
| September 30, 2024 | $21.44B | -7.6% | -0.5% |
| June 30, 2024 | $21.54B | +1.6% | +0.1% |
| March 31, 2024 | $21.53B | -6.2% | -7.2% |
| December 31, 2023 | $23.19B | +1.0% | +0.0% |
- GILEAD SCIENCES, INC. showed a decrease of -11.1% in Long-Term Debt compared to the prior fiscal year.
- Over the 2012–2025 period, GILEAD SCIENCES, INC.’s long-term debt has grown by 213.7% (from $7.05 billion to $22.13 billion).
- The most recent figure is from GILEAD SCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: